6,000 heart patients to be studied for better valve care
NCT ID NCT07230756
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow 6,000 people in China who have both coronary heart disease and a leaky heart valve (ischemic mitral regurgitation). Researchers will collect medical data and track outcomes like hospitalizations and deaths over two years. The goal is to understand the disease better and find ways to improve diagnosis and treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide doctors with better tools to predict and manage heart valve problems in people with coronary heart disease.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new drug or procedure, so it cannot directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE (CHD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an AI trained on real heart patients outsmart generic chatbots?
- Can your smartwatch replace a medical heart test? scientists put apple watch to the test
- Yam gruel shows promise for heart health after stent surgery
- Heart patients may need only one blood thinner after balloon treatment, major trial tests
- Exercise test may reveal hidden heart dangers in 15,000 patients
- Heart patients get rehab via smartphone app in new study